ONK Therapeutics

OverviewSuggest Edit

ONK Therapeutics is a company that develops natural killer cell-based therapies intended to target blood cancer with unmet needs. Its technology offers optimization of natural-killer cells including the expression of chimeric antigen receptors, high-affinity CD16, novel trail variants as well as silencing novel immune checkpoints.
HQBarna, IE

Latest Updates

Employees (est.) (Jan 2022)24(-4%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at ONK Therapeutics

Chris Nowers

Chris Nowers

CEO & Director
Michael O'Dwyer

Michael O'Dwyer

Founder, CSO & Director
Mary Reilly

Mary Reilly

Chief Operating Officer
Hugh O'Dowd

Hugh O'Dowd

Director & Chairman
Eunan Maguire

Eunan Maguire

Anthony Killarney

Anthony Killarney

Founder & Director
Show more

ONK Therapeutics Office Locations

ONK Therapeutics has an office in Barna
Barna, IE (HQ)
Apartment 5, An Coirnéal, Seapoint
Show all (1)

ONK Therapeutics Financials and Metrics

Summary Metrics

Founding Date


ONK Therapeutics total Funding

$14.6 m

ONK Therapeutics latest funding size

$8 m

Time since last funding

a year ago

ONK Therapeutics investors

ONK Therapeutics's latest funding round in October 2020 was reported to be $8 m. In total, ONK Therapeutics has raised $14.6 m
Show all financial metrics

ONK Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

ONK Therapeutics Online and Social Media Presence

Embed Graph

ONK Therapeutics News and Updates

Glycotope announces licensing agreement with ONK Therapeutics for humanized GlycoBody targeting TA-MUC1

Glycotope announces licensing agreement with ONK Therapeutics for humanized GlycoBody targeting TA-MUC1

ONK Therapeutics Closes US$8M Financing

ONK Therapeutics Ltd, a Galway, Ireland-based natural killer (NK) cell therapy company, raised US$8M in financing. This round, which brought the total raised in the last six months to US$14.6M, was led by Acorn Bioventures, and current shareholders, principally Seamus Mulligan, an experienced biopha…

ONK Therapeutics Frequently Asked Questions

  • When was ONK Therapeutics founded?

    ONK Therapeutics was founded in 2015.

  • Who are ONK Therapeutics key executives?

    ONK Therapeutics's key executives are Chris Nowers, Michael O'Dwyer and Mary Reilly.

  • How many employees does ONK Therapeutics have?

    ONK Therapeutics has 24 employees.

  • Who are ONK Therapeutics competitors?

    Competitors of ONK Therapeutics include ADC Therapeutics, Q2 Solutions and Erbi Biosystems.

  • Where is ONK Therapeutics headquarters?

    ONK Therapeutics headquarters is located at Apartment 5, An Coirnéal, Seapoint, Barna.

  • Where are ONK Therapeutics offices?

    ONK Therapeutics has an office in Barna.

  • How many offices does ONK Therapeutics have?

    ONK Therapeutics has 1 office.